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Abstract
© The Author(s) 2017. Biofilms, the communities of surface-attached bacteria embedded into
extracellular  matrix,  are ubiquitous microbial  consortia  securing the effective resistance of
constituent  cells  to  environmental  impacts  and host  immune responses.  Biofilm-embedded
bacteria are generally inaccessible for antimicrobials, therefore the disruption of biofilm matrix
is the potent approach to eradicate microbial biofilms. We demonstrate here the destruction of
Staphylococcus aureus and Staphylococcus epidermidis biofilms with Ficin, a nonspecific plant
protease. The biofilm thickness decreased two-fold after 24 hours treatment with Ficin at 10
μg/ml and six-fold at 1000 μg/ml concentration. We confirmed the successful destruction of
biofilm structures and the significant decrease of non-specific bacterial adhesion to the surfaces
after Ficin treatment using confocal laser scanning and atomic force microscopy. Importantly,
Ficin treatment enhanced the effects of antibiotics on biofilms-embedded cells via disruption of
biofilm matrices. Pre-treatment with Ficin (1000 μg/ml) considerably reduced the concentrations
of ciprofloxacin and bezalkonium chloride required to suppress the viable Staphylococci by 3
orders of magnitude. We also demonstrated that Ficin is not cytotoxic towards human breast
adenocarcinoma cells (MCF7) and dog adipose derived stem cells. Overall, Ficin is a potent tool
for  staphylococcal  biofilm treatment and fabrication of  novel  antimicrobial  therapeutics  for
medical and veterinary applications.
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